Loading viewer...
investor_presentation
Format: PDF investor_presentation
3rdQuarter Earnings Presentation Pat Gelsinger Chief Executive Officer George Davis Executive Vice President and Chief Financial Officer
Earnings Presentation
Chief Executive Officer
Executive Vice President and Chief Financial Officer2• This presentation contains non -GAAP financial measures. Intel revenue, gross margin, and earnings per share are presented on a n on-GAAP basis unless
otherwise indicated. This presentation also includes a non -GAAP free cash flow (FCF) measure. The Appendix provides a reconcili ation of these measures
to the most directly comparable GAAP financial measure. The non -GAAP financial measures disclosed by Intel should not be conside red a substitute for, or
superior to, the financial measures prepared in accordance with GAAP. Please refer to “Explanation of Non -GAAP Measures” in Int el's quarterly earnings
release for a detailed explanation of the adjustments made to the comparable GAAP measures, the ways management uses the non -GAA P measures, and
the reasons why management believes the non -GAAP measures provide investors with useful supplemental information.
• Statements in this presentation that refer to business outlook, plans, and expectations are forward -looking statements that invo lve risks and uncertainties.
Words such as "anticipate," "expect," "intend," "goal," "plans," "believe," "seek," "estimate," "continue,“ “committed,” “on -track,” ”positioned,” “ramp,”
“momentum,” “roadmap,” “pipeline,” “progress,” “forecast,” “likely,” “guide,” “potential,” “future,” “next -gen,” "may," "will," “would,” "should," “could,” and
variations of such words and similar expressions are intended to identify such forward -looking statements. Statements that refer to or are based on
estimates, forecasts, projections, uncertain events or assumptions, including statements relating to Intel’s strategy; manufa cturing expansion and investment
plans; financial projections; future dividends and returns to shareholders; plans and goals related to Intel’s foundry busine ss;total addressable market (TAM)
and market opportunity; future impacts of the COVID -19 pandemic; future legislation; future products, technology, and services, and the expected availability
and benefits of such products, technology, and services, including product ramps, Sapphire Rapids and Alchemist timing, and m anu facturing plans, goals,
timelines, and future progress, including expectations regarding process performance parity and leadership and process techno logy timelines issued in July
2021; pending transactions including the pending sale of our NAND memory business; supply expectations, including regarding i ndu stry shortages and
sufficiency of future supply; future external foundry usage; expectations regarding customers, including designs, wins, order s, and partnerships; projections
regarding competitors; business plans and financial expectations; and anticipated trends in our businesses or the markets rel eva nt to them, including future
demand and industry growth, also identify forward -looking statements. Such statements involve many risks and uncertainties that could cause actual results
Preview truncated — download the full document for the complete content.
conference
12 Pages
investor_presentation
48 Pages
Lyell Immunopharma, Inc.
Tonix Pharmaceuticals Investor Presentation 2022
investor_presentationinvestor_presentation
40 Pages
Tonix Pharmaceuticals Holding Corp.